- Home
- HCA vs BDX Comparison
HCA vs BDX Comparison
Compare HCA & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCA
- BDX
- Stock Information
- Founded
- HCA 1968
- BDX 1897
- Country
- HCA United States
- BDX United States
- Employees
- HCA N/A
- BDX N/A
- Industry
- HCA Hospital/Nursing Management
- BDX Medical/Dental Instruments
- Sector
- HCA Health Care
- BDX Health Care
- Exchange
- HCA Nasdaq
- BDX Nasdaq
- Market Cap
- HCA 79.4B
- BDX 64.9B
- IPO Year
- HCA N/A
- BDX 1962
- Fundamental
- Price
- HCA $342.38
- BDX $227.60
- Analyst Decision
- HCA Buy
- BDX Strong Buy
- Analyst Count
- HCA 16
- BDX 7
- Target Price
- HCA $380.20
- BDX $278.29
- AVG Volume (30 Days)
- HCA 1.6M
- BDX 2.0M
- Earning Date
- HCA 04-25-2025
- BDX 05-01-2025
- Dividend Yield
- HCA 0.84%
- BDX 1.82%
- EPS Growth
- HCA 15.97
- BDX 41.25
- EPS
- HCA 22.00
- BDX 5.94
- Revenue
- HCA $70,603,000,000.00
- BDX $20,640,000,000.00
- Revenue This Year
- HCA $6.79
- BDX $9.21
- Revenue Next Year
- HCA $5.16
- BDX $4.97
- P/E Ratio
- HCA $15.56
- BDX $38.49
- Revenue Growth
- HCA 8.67
- BDX 5.89
- 52 Week Low
- HCA $289.98
- BDX $218.75
- 52 Week High
- HCA $417.14
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- HCA 61.53
- BDX 50.18
- Support Level
- HCA $332.84
- BDX $226.48
- Resistance Level
- HCA $342.74
- BDX $230.95
- Average True Range (ATR)
- HCA 8.75
- BDX 3.58
- MACD
- HCA 1.73
- BDX 0.34
- Stochastic Oscillator
- HCA 93.96
- BDX 59.93
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.